Last $113.87 USD
Change Today +0.37 / 0.33%
Volume 540.2K
HSIC On Other Exchanges
Symbol
Exchange
Munich
NASDAQ GS
As of 8:10 PM 04/17/14 All times are local (Market data is delayed by at least 15 minutes).

henry schein inc (HSIC) Snapshot

Open
$113.75
Previous Close
$113.50
Day High
$115.49
Day Low
$113.55
52 Week High
04/4/14 - $120.99
52 Week Low
04/23/13 - $88.90
Market Cap
9.7B
Average Volume 10 Days
489.3K
EPS TTM
$4.96
Shares Outstanding
85.5M
EX-Date
--
P/E TM
23.0x
Dividend
--
Dividend Yield
--
Current Stock Chart for HENRY SCHEIN INC (HSIC)

Related News

No related news articles were found.

henry schein inc (HSIC) Related Businessweek News

View More BusinessWeek News

henry schein inc (HSIC) Details

Henry Schein, Inc. distributes health care products and services worldwide. It operates in two segments, Health Care Distribution, and Technology and Value-Added Services. The Health Care Distribution segment offers dental products, such as infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, dental implants, gypsum, acrylics, articulators, abrasives, dental chairs, delivery units and lights, X-ray supplies and equipment, equipment repair, and high-tech equipment. This segment also provides animal health products consisting of branded and generic pharmaceuticals, surgical and consumable products and services, and equipment; and medical products, comprising branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products, X-ray products, equipment, and vitamins. The Technology and Value-Added Services segment offers software, technology, and other value-added services and products, including practice management software systems for dental and medical practitioners, and animal health clinics. This segment also provides value-added practice solutions comprising financial services on a non-recourse basis, e-services, and continuing education services for practitioners. The company primarily serves dental practitioners and laboratories, physician practices, and animal health clinics, as well as government, institutional health care clinics, and other alternate care clinics. Henry Schein, Inc. was founded in 1932 and is headquartered in Melville, New York.

16,000 Employees
Last Reported Date: 02/11/14
Founded in 1932

henry schein inc (HSIC) Top Compensated Officers

Executive Chairman and Chief Executive Office...
Total Annual Compensation: $1.2M
President, Chief Operating Officer, Executive...
Total Annual Compensation: $744.2K
Chief Financial Officer, Principal Accounting...
Total Annual Compensation: $587.2K
Chief Administrative Officer, Executive Vice ...
Total Annual Compensation: $557.2K
Senior Advisor
Total Annual Compensation: $507.2K
Compensation as of Fiscal Year 2013.

henry schein inc (HSIC) Key Developments

Henry Schein Announces Release of Dentrix Ascend

Henry Schein, Inc. announced the availability of Dentrix Ascend, its first cloud-based practice management system. Having completed beta testing, Dentrix Ascend features a web-based practice management system that enhances dental practice efficiency by providing the benefits of the cloud, including automatic data backup, upgrades delivered in small, easily learned modules, and round-the-clock access from any model of computer--Personal Computer, Macintosh or tablet. Dentrix Ascend offers a unique approach to managing office workflow in the way it delivers real-time information.

Sysmex America, Inc. and Henry Schein, Inc. Sign a Three-Year Distribution Agreement

Sysmex America, Inc. and Henry Schein, Inc. announced the signing of a three-year distribution agreement between the companies effective immediately. Under the agreement, Henry Schein will represent Sysmex's pocH-100i(TM), XP-300(TM), XN-1000(TM), XN-2000(TM), XS-1000i(TM) and the XT-4000i(TM) automated hematology analyzers in the alternate care setting.

The Procter & Gamble Company Selects Henry Schein, Inc. as Exclusive Veterinary Distributor of Iams(R) Therapeutic Diet Formulas

The Procter & Gamble Company and Henry Schein, Inc. announced a new agreement under which Henry Schein will be the exclusive distributor of P&G's Iams(R) therapeutic diet formulas to veterinary practices in the contiguous United States. Under the new agreement, Henry Schein Animal Health, the U.S. animal health division of Henry Schein, will be the exclusive distributor of Iams' therapeutic line of dog and cat food solutions, including special formulas to help nutritionally manage pet health concerns such as digestive imbalance, skin & coat, weight management and joint and urinary issues. Henry Schein will distribute the Iams' therapeutic and wellness diets as part of a complete portfolio of pet nutritional solutions it offers to veterinarians throughout the United States.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
HSIC:US $113.87 USD +0.37

HSIC Competitors

Market data is delayed at least 15 minutes.

Company Last Change
CareFusion Corp $38.50 USD +0.15
CGI Group Inc C$36.33 CAD +0.16
CR Bard Inc $139.49 USD +0.23
Tractor Supply Co $67.25 USD +0.36
Varian Medical Systems Inc $80.28 USD -0.61
View Industry Companies
 

Industry Analysis

HSIC

Industry Average

Valuation HSIC Industry Range
Price/Earnings 23.1x
Price/Sales 1.0x
Price/Book 3.5x
Price/Cash Flow 22.6x
TEV/Sales 0.9x
 | 

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact HENRY SCHEIN INC, please visit www.henryschein.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.